fda stops tirzepatide Lilly's weight-loss drug removed from FDA's shortage list FDA Announces End To Compounded

Eriksson 1

Clinical trial data shows that burping rates vary by drug and dose: Ozempic injection (semaglutide): Burping reported in 3% of patients at the 0.5 mg dose and 1% of patients at the 1 mg dose Wegovy injection (semaglutide): Burping reported in 7% of adults at the 2.4 mg dose Mounjaro and Zepbound (tirzepatide): Burping reported in 25% of patients across doses (Source: Drugs.com) These numbers likely underestimate real-world prevalence, as sulfur burps are often underreported in clinical trials or described under broader terms like belching or eructation. Some patients avoid mentioning it to their doctors out of embarrassment, as well

If you do not have insurance, or if insurance doesn't cover the cost, our weight loss program in Bronx, New York offers affordable self-pay options as well

The math adjusts

PlexusDx works with qualified healthcare providers who personalize your dosing timeline based on your medical history, current medications, and weight loss goals

For weight loss, its called Wegovy